Logipharma 2016 (past event)
19 - 21 April, 2016
44 (0) 20 7368 9854
Conference day three - Thursday 21 April 2016
08:15 - 08:50 Welcome Coffee
08:50 - 09:00 Chairman’s opening address
09:00 - 09:40 ALL STAR PANEL – Supply chain 2030 - How can you achieve a truly integrated end-to-end supply chain across the business: R&D, Manufacturing, Commercial and Supply Chain?
Speakers:
Simon Orchard Vice President, EMEA Supply Operations & Customer Support Pfizer
Sheena Behn VP, Commercial Operations, Global Supply Chain and Strategy AstraZeneca
Michael Sauter Former Senior Director Digital Health Technologies Biogen
Moderator:
Marcus Hayek Managing Director Accenture Strategy
Simon Orchard Vice President, EMEA Supply Operations & Customer Support Pfizer
Sheena Behn VP, Commercial Operations, Global Supply Chain and Strategy AstraZeneca
Michael Sauter Former Senior Director Digital Health Technologies Biogen
Moderator:
Marcus Hayek Managing Director Accenture Strategy
An exemplary panel of industry leaders share their unique perspective on achieving a truly integrated supply chain.
•What top three changes would R&D, Manufacturing and Commercial like to see from Supply Chain?
•What steps can be put in place to coordinate tech transfer early on with R&D and Manufacturing?
•What are the best ways to work together at product launch to facilitate market access, business opportunities and regulatory compliance?
•How can supply chain best communicate key learnings with commercial to influence high-level commercial decisions?
•What top three changes would R&D, Manufacturing and Commercial like to see from Supply Chain?
•What steps can be put in place to coordinate tech transfer early on with R&D and Manufacturing?
•What are the best ways to work together at product launch to facilitate market access, business opportunities and regulatory compliance?
•How can supply chain best communicate key learnings with commercial to influence high-level commercial decisions?
09:40 - 10:00 KEYNOTE PRESENTATION - Operations at AstraZeneca Delivering our bold ambition - and the next stage in our Operations and Supply Chain Journey
Per leads the global supply chain and strategy with overall end-to-end supply chain oversight. Per orchestrates AstraZeneca’s supply chains through their design, establishment, planning and optimization. Per is viewed as a leading pioneer in strategy development for Global Operations and lead Global Operations business development efforts.
•Outlining the main steps in our cutting-edge road map
•To what extent can end-to-end visibility contribute to profitability and how?
•How to win the hearts and minds of internal in prioritising visibility
•How to effectively engage external partners with your end-to-end visibility road map
•Outlining the main steps in our cutting-edge road map
•To what extent can end-to-end visibility contribute to profitability and how?
•How to win the hearts and minds of internal in prioritising visibility
•How to effectively engage external partners with your end-to-end visibility road map
10:00 - 10:20 Direct-to-patient: How to deliver a best-in-class customer experience by understanding country requirements and differentiating your service
•How should pharma, wholesalers and 3PLs best work with local authorities to deliver the best service?
•What are the options for coordinating product delivery with local healthcare providers
•What are the stand-out specific country requirements for direct-to-patient delivery
•What are the real outcomes and benefits of direct-to-patient delivery – is it really better for the patient?
•What are the options for coordinating product delivery with local healthcare providers
•What are the stand-out specific country requirements for direct-to-patient delivery
•What are the real outcomes and benefits of direct-to-patient delivery – is it really better for the patient?
10:20 - 11:00 Morning networking break
11:00 - 11:20 Exploring new ways to use digital technology to deliver a customer-first experience
11:20 - 23:40 Examining the global trends affecting healthcare – what can pharma supply chains expect?
•Outlining the main trends affecting healthcare in the next five years •Examining what this will mean for pharma supply chain
•Assessing the impact of increasingly complex and changing product portfolios
•Evaluating future predictions for direct to hospital and pharmacy distribution
•Assessing the impact of increasingly complex and changing product portfolios
•Evaluating future predictions for direct to hospital and pharmacy distribution
23:40 - 00:20 CASE STUDY INTERACTIVE: AbbVie’s story: How to redesign your distribution, transportation and warehouse network following a company split
00:20 - 12:40 OUT OF INDUSTRY: How to design a pioneering flexible distribution network to truly meet the needs of your customer: What can pharma learn from experience in a rapidly developing online retail world?
12:40 - 13:40 Networking Lunch
Track A - Supply Chain Strategy: Value and Profitability
13:40 - 13:45 Chairman’s opening address
SYNERGY WORKSHOP - Cold Chain
13:40 - 13:45 Cold-chain design for specialty products: What transportation and equipment decisions would you take if you could design your cold-chain for specialty products from scratch?
SYNERGY WORKSHOP - Sourcing and Procurement
13:40 - 13:45 How to establish a stronger relationship with your supply chain stakeholders whilst and effectively sourcing, managing and working with your providersLaurent Foetisch
Managing DirectorSupply Chain Operations
Track A
13:45 - 14:05 How to design your global network to ensure your business capitalises on the demands of your rapidly changing portfolio
Karine’s main goal through her role is to develop global supply chain operations, standardise practices and develop visual management, dashboards and SOPs. Karine has identified the importance of focusing on improving service and financial inefficiencies in infrastructure and transport (OS, flows Optimization, Distribution opportunities) and applies this in Network Optimisation studies in EMEA, LATAM and APAC. Karine is also involved in the Gambro integration team to ensure identified optimization projects are properly scoped and executed.
•How to make key decisions on where to place your plants and distribution warehouse sites to optimise market access
•Which supply chain models are most effective?
•How can you use scenario planning to help design your network? •How to ensure that your global network design will meet the local regulatory
•How to make key decisions on where to place your plants and distribution warehouse sites to optimise market access
•Which supply chain models are most effective?
•How can you use scenario planning to help design your network? •How to ensure that your global network design will meet the local regulatory
SYNERGY WORKSHOP - Cold Chain
13:45 - 14:05 Track B continuedSYNERGY WORKSHOP - Sourcing and Procurement
13:45 - 14:05 Track C continuedTrack A
14:05 - 14:25 INTERVIEW: How organisations are developing their people to meet the needs of the future?•Many organisations are clear about their supply chain vision for 2020 and beyond
•Process excellence is critical – in both new and old capabilities •This interview explores practical examples of how organisations are approaching this very real challenge
SYNERGY WORKSHOP - Cold Chain
14:05 - 14:25 Track B continuedSYNERGY WORKSHOP - Sourcing and Procurement
14:05 - 14:25 Track C continued14:25 - 14:40 Afternoon Networking Break
14:40 - 15:20 ALL STAR PANEL: Supply chain network redesign: How can you best integrate legacy infrastructure with new flows to meet your latest business requirements?
This panel brings together experts in logistics and project development to discuss the latest strategies in incorporating legacy infrastructure within their company.
•How to adapt and implement new distribution strategies to meet new business requirements
•Integrating new infrastructure and processes following a merger •How to critically assess which company structures and processes to keep in place and which to evolve
•How should you reorganize your internal structure to meet business requirements?
•How should you best work with external partners
•How to prioritise which new systems will provide the greatest return on investment Eric Hutin, Global Logistics Director, MSD Karine Javelle, Supply Chain Project Development and Compliance Manager, Baxter Healthcare
•How to adapt and implement new distribution strategies to meet new business requirements
•Integrating new infrastructure and processes following a merger •How to critically assess which company structures and processes to keep in place and which to evolve
•How should you reorganize your internal structure to meet business requirements?
•How should you best work with external partners
•How to prioritise which new systems will provide the greatest return on investment Eric Hutin, Global Logistics Director, MSD Karine Javelle, Supply Chain Project Development and Compliance Manager, Baxter Healthcare
15:20 - 16:00 Corporate Social Responsibility within the Supply Chain process…to save lives
•What simple steps can you take to help support health projects? •How can you adapt transportation, distribution and procurement activities with corporate and social responsibility in mind
•What can you do to get buy-in from your internal and external stakeholders?
•How to keep your customers informed of your corporate social responsibility processes Adele is directly responsible for finding, creating and maintaining opportunities for global pharmaceutical and supplies companies to support health projects and respond to disasters across the world.
•What can you do to get buy-in from your internal and external stakeholders?
•How to keep your customers informed of your corporate social responsibility processes Adele is directly responsible for finding, creating and maintaining opportunities for global pharmaceutical and supplies companies to support health projects and respond to disasters across the world.
